Cerimon Pharmaceuticals

Cerimon Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes treatments for autoimmune diseases, inflammation, and pain in the United States and Europe. It has developed Simulect, a monoclonal antibody for treating moderate to severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug used to treat various types of pain, including musculoskeletal injuries and pain caused by lower back issues; and topical diclofenac sodium patch products.